Juan Manuel Ramos-Goni
Overview
Explore the profile of Juan Manuel Ramos-Goni including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
526
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rand K, Ramos-Goni J, Akmaz B, Sole-Feu L, Armario-Hita J
Dermatol Ther (Heidelb)
. 2024 Mar;
14(3):823-827.
PMID: 38438784
No abstract available.
2.
Rand K, Ramos-Goni J, Akmaz B, Sole-Feu L, Armario-Hita J
Dermatol Ther (Heidelb)
. 2024 Jan;
14(1):183-185.
PMID: 38245639
No abstract available.
3.
Chang J, Hsu C, Ramos-Goni J, Luo N, Lin H, Lin F
Eur J Health Econ
. 2023 Dec;
25(6):1041-1055.
PMID: 38072877
Background: A fixed 10-year lead-time in composite time-trade-off (C-TTO) tasks might compromise the precision of utility values below - 1. This study explored how alternative lead-times (ALTs) influence EQ-5D-5L value...
4.
Rand K, Ramos-Goni J, Akmaz B, Sole-Feu L, Armario-Hita J
Dermatol Ther (Heidelb)
. 2023 Oct;
14(1):169-182.
PMID: 37897645
Introduction: Lebrikizumab and dupilumab are monoclonal antibodies approved for treating moderate-to-severe atopic dermatitis (AD). Both have demonstrated efficacy and safety over the 16-week SOLOs and ADvocate trials. However, AD is...
5.
Valcarcel-Nazco C, Ramallo-Farina Y, Linertova R, Ramos-Goni J, Garcia-Perez L, Serrano-Aguilar P
Int J Environ Res Public Health
. 2022 Jul;
19(13).
PMID: 35805867
Most of rare disease (RD) patients are assisted in their homes by their family as informal caregivers, causing a substantial burden among family members devoted to care. The role of...
6.
Mott D, Shah K, Ramos-Goni J, Devlin N, Rivero-Arias O
Med Decis Making
. 2021 Mar;
41(5):584-596.
PMID: 33733920
Background: An important question in the valuation of children's health is whether the preferences of younger individuals should be captured within value sets for measures that are aimed at them....
7.
Shah K, Ramos-Goni J, Kreimeier S, Devlin N
Eur J Health Econ
. 2020 Jun;
21(7):1091-1103.
PMID: 32506281
Objectives: Discrete choice experiments (DCEs) can be used to obtain latent scale values for the EQ-5D-Y, but these require anchoring at 0 = dead to meet the conventions of quality-adjusted...
8.
Lopez-Bastida J, Ramos-Goni J, Aranda-Reneo I, Taruscio D, Magrelli A, Kanavos P
Orphanet J Rare Dis
. 2019 Jun;
14(1):154.
PMID: 31242905
Background: Decision makers have huge problems when attempting to attribute social value to the improvements achieved by new drugs, especially when considering the use of orphan drugs for rare diseases....
9.
Stolk E, Ludwig K, Rand K, van Hout B, Ramos-Goni J
Value Health
. 2019 Jan;
22(1):23-30.
PMID: 30661630
A standardized 5-level EuroQol 5-dimensional questionnaire (EQ-5D-5L) valuation protocol was first used in national studies in the period 2012 to 2013. A set of problems encountered in this initial wave...
10.
Arrospide A, Ramos-Goni J, Pechlivanoglou P, Mar J
Gac Sanit
. 2018 Dec;
34(1):91-95.
PMID: 30554736
This study aimed to explain a joint statistical procedure (two-part models and Cholesky decomposition) to incorporate second-order uncertainty from covariate adjusted mean utility functions in probabilistic cost-effectiveness models. First, two-part...